Form 4: HCA Healthcare Director Andrea B. Smith Reports Stock Award and Managed Account Holdings

Sentiment:

SEC Form 4 Filing


Director Andrea B. Smith reports the acquisition of common stock related to restricted share units and holdings in managed accounts.

Summary

  • Andrea B. Smith, a director of HCA Healthcare, Inc., filed a Form 4 on May 1, 2025.
  • The report details changes in her beneficial ownership of HCA common stock.
  • Smith acquired 645 shares of common stock on April 29, 2025, related to restricted share units from an annual director equity award.
  • These shares will vest on the earlier of the company's 2026 annual shareholders' meeting or the first anniversary of the grant date.
  • Vested shares will be delivered upon Smith ceasing to be a board member.
  • The report also indicates that Smith indirectly owns 82 shares through managed accounts over which she has no investment authority.

Sentiment

Score: 7

Explanation: The sentiment is neutral to slightly positive. The filing reflects standard corporate governance practices and aligns director interests with shareholders through equity ownership.

Positives

  • The acquisition of shares through equity awards aligns the director's interests with those of the shareholders.
  • The vesting schedule encourages long-term commitment to the company's success.

Future Outlook

The report does not contain any specific forward-looking statements regarding HCA Healthcare's future performance.

Industry Context

Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. This filing indicates standard compensation practices for board members.

Comparison to Industry Standards

  • Director compensation packages often include equity awards to align director and shareholder interests.
  • Vesting schedules are a common mechanism to ensure long-term commitment.
  • The size of the equity award appears consistent with standard practices for directors at similarly sized healthcare companies.

Stakeholder Impact

  • The report provides transparency to shareholders regarding director compensation and ownership.
  • The equity award aligns the director's interests with those of the shareholders, potentially encouraging decisions that benefit the company's long-term performance.

Key Dates

DateDescription
04/29/2025Date of transaction: Acquisition of common stock.
05/01/2025Date of Form 4 filing.
2026Vesting date of restricted share units, contingent on the annual shareholders' meeting.

Keywords

HCA Healthcare, Form 4, Director, Stock, Beneficial Ownership, Equity Award, Managed Accounts, Vesting

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.